The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics
- 15 August 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 281 (3) , 319-326
- https://doi.org/10.1016/0014-2999(95)00266-n
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in miceEuropean Journal of Pharmacology, 1995
- Glutamate antagonists have different effects on spontaneous locomotor activity in ratsPharmacology Biochemistry and Behavior, 1994
- Competitive antagonist of NMDA receptors, CGP 37849 and CGP 39551, enhance the anticonvulsant activity of valproate against electroconvulsions in miceEuropean Journal of Pharmacology, 1993
- GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responsesNeuron, 1993
- The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in miceEpilepsy Research, 1991
- Modulation of memory processing by glutamic acid receptor agonists and antagonistsBrain Research, 1990
- Effects of excitatory amino-acid antagonists on the anticonvulsant action of phenobarbital or diphenylhydanton in miceEuropean Journal of Pharmacology, 1984
- Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acidEuropean Journal of Pharmacology, 1982
- Anticonvulsant Action of Excitatory Amino Acid AntagonistsScience, 1982
- Une nouvelle méthode simple pour explorer l’action «tranquillisante»: le test de la cheminéePharmacology, 1960